bioRxiv Science⌕ Search

Biology subjects

Torun, A.

Publications and source records attributed to Torun, A..

2 recordsLinked to original sources

Actinomycin D Drives RNA-Binding Proteins into Dynamic Cytoplasmic Granules

Actinomycin D (Act D) is a global transcriptional inhibitor widely used in research and clinical practice; however, its effects on RNA-binding protein (RBP) dynamics remain poorly understood. Analysis of an RNA-seq dataset from Act D-treated HeLa cells revealed a compensatory stress response enriched in RNA metabolism, processing, and translation. Here, we investigated the effects of Act D on the subcellular localization of RBPs using HuR as a model mRNA stabilizing RBP. Short-term Act D treatment markedly increased cytoplasmic HuR localization in HCT116 and HeLa cells where the protein is known to be active. Analysis of known pathways regulating HuR nucleocytoplasmic translocation did not fully explain this redistribution, suggesting alternative mechanisms. To identify proteins proximal to HuR following Act D treatment, we performed TurboID labeling followed by LC-MS/MS in HCT116 cells. Several proteins involved in RNA regulation were identified. Probabilistic modeling highlighted FUS, an RBP with established roles in phase-separated granule dynamics, as a candidate proximal protein. The Act D-dependent interaction between HuR and FUS was interrogated using molecular dynamics simulations and validated with proximity ligation assays. Furthermore, increased cytoplasmic localization of RBPs following Act D treatment was accompanied by formation of granular structures that were relatively fluid and could be disrupted by hypotonic shock. Collectively, our findings demonstrate that Act D induces cytoplasmic redistribution of multiple RBPs and their sequestration into dynamic granular structures, revealing a previously unrecognized cellular response to transcriptional inhibition. Graphical AbstractAct D induced cytoplasmic re-localization of HuR along with FUS and other RBPs in dynamic, hypotonic shock-sensitive granular structures. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=93 SRC="FIGDIR/small/745449v1_ufig1.gif" ALT="Figure 1"> View larger version (36K): org.highwire.dtl.DTLVardef@f04186org.highwire.dtl.DTLVardef@15dcb0corg.highwire.dtl.DTLVardef@bdbaf9org.highwire.dtl.DTLVardef@3e54b1_HPS_FORMAT_FIGEXP M_FIG C_FIG

cell biology↗

Engineering Microbial R- and S- β-Hydroxybutyrate Production

Beta-hydroxybutyrate (BHOB) is a therapeutically valuable enantiomeric ketone body that is synthesized by both prokaryotes and eukaryotes. Bacterial synthesis of BHOB has so far mostly been exploited for the synthesis of biofuels and to a lesser extent for the pharmaceutical industry. In this study, we carefully evaluated the expression, induction, selection, and detection elements and identified multigene pathways to direct the synthesis of physiologically relevant amounts of BHOB. Utilizing the reversal of the beta-oxidation pathway that has previously been used for biofuel generation, we engineered E. coli strains with a prebiotic-activated circuit to secrete either (S)-BHOB or (R)-BHOB. Our findings demonstrate high-yield microbial BHOB production with a defined enantiomeric composition and highlight its therapeutic potential for cancer and gut-brain axis involving disorders. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=134 SRC="FIGDIR/small/664879v1_ufig1.gif" ALT="Figure 1"> View larger version (27K): org.highwire.dtl.DTLVardef@8bf92corg.highwire.dtl.DTLVardef@193f067org.highwire.dtl.DTLVardef@18c0e7dorg.highwire.dtl.DTLVardef@b6293_HPS_FORMAT_FIGEXP M_FIG C_FIG

synthetic biology↗